Back to Search
SRDAN VERSTOVSEK, M.D., PHD
M.D., PHD
Medical Oncology Physician
NPI: 1598864100Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
K8552(TX)
Research & Publications (20)
Preclinical and clinical experience with dasatinib in Philadelphia chromosome-negative leukemias and myeloid disorders.
PMID 19013641·Leuk Res·2009
6-review
Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001.
PMID 19484334·Int J Hematol·2009
3-trial
Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemia.
PMID 19118067·Clin Cancer Res·2009
8-other
Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias.
PMID 19074595·J Mol Diagn·2009
8-other
Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis.
PMID 18559612·Clin Cancer Res·2008
3-trial
WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation.
PMID 18245540·Clin Cancer Res·2008
8-other
Effects of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, on human mast cells bearing wild-type or mutated codon 816 c-kit.
PMID 16797704·Leuk Res·2006
8-other
Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?
PMID 16783836·Hematol Oncol·2006
6-review
Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells.
PMID 16682077·Leuk Res·2006
8-other
AMN107, a novel aminopyrimidine inhibitor of p190 Bcr-Abl activation and of in vitro proliferation of Philadelphia-positive acute lymphoblastic leukemia cells.
PMID 16078266·Cancer·2005
8-other
Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia.
PMID 15158092·Leuk Res·2004
8-other
Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia.
PMID 12712473·Cancer·2003
8-other
Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia.
PMID 12681367·Leuk Res·2003
4-observational
Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia.
PMID 12599232·Cancer·2003
8-other
Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome.
PMID 12100142·Br J Haematol·2002
8-other
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course.
PMID 12015767·Cancer·2002
8-other
Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia.
PMID 11920509·Cancer·2002
8-other
Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia.
PMID 11877311·Blood·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1598864100
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile